Targeting efflux pumps to overcome antifungal drug resistance
- Author(s)
- Holmes, AR; Cardno, TS; Strouse, JJ; Ivnitski-Steele, I; Keniya, MV; Lackovic, K; Monk, BC; Sklar, LA; Cannon, RD;
- Journal Title
- Future Medicinal Chemistry
- Publication Type
- Journal Article
- Abstract
- Resistance to antifungal drugs is an increasingly significant clinical problem. The most common antifungal resistance encountered is efflux pump-mediated resistance of Candida species to azole drugs. One approach to overcome this resistance is to inhibit the pumps and chemosensitize resistant strains to azole drugs. Drug discovery targeting fungal efflux pumps could thus result in the development of azole-enhancing combination therapy. Heterologous expression of fungal efflux pumps in Saccharomyces cerevisiae provides a versatile system for screening for pump inhibitors. Fungal efflux pumps transport a range of xenobiotics including fluorescent compounds. This enables the use of fluorescence-based detection, as well as growth inhibition assays, in screens to discover compounds targeting efflux-mediated antifungal drug resistance. A variety of medium- and high-throughput screens have been used to identify a number of chemical entities that inhibit fungal efflux pumps.
- Publisher
- Future Science Group
- Research Division(s)
- Chemical Biology
- PubMed ID
- 27463566
- Link To PubMed Central Version
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827819/
- Publisher's Version
- https://doi.org/10.4155/fmc-2016-0050
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2016-08-10 04:12:54
Last Modified: 2018-07-11 09:24:20